Starpharma Holdings Limited

ASX:SPL Stock Report

Market Cap: AU$51.5m

Starpharma Holdings Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Cheryl Maley

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenureno data
Board average tenure1.9yrs

Recent management updates

Recent updates

Does Starpharma Holdings (ASX:SPL) Have A Healthy Balance Sheet?

Dec 18
Does Starpharma Holdings (ASX:SPL) Have A Healthy Balance Sheet?

We Think Some Shareholders May Hesitate To Increase Starpharma Holdings Limited's (ASX:SPL) CEO Compensation

Nov 22
We Think Some Shareholders May Hesitate To Increase Starpharma Holdings Limited's (ASX:SPL) CEO Compensation

Here's Why Starpharma Holdings (ASX:SPL) Can Manage Its Debt Despite Losing Money

Mar 21
Here's Why Starpharma Holdings (ASX:SPL) Can Manage Its Debt Despite Losing Money

We're Hopeful That Starpharma Holdings (ASX:SPL) Will Use Its Cash Wisely

Jan 26
We're Hopeful That Starpharma Holdings (ASX:SPL) Will Use Its Cash Wisely

We Think Starpharma Holdings (ASX:SPL) Can Afford To Drive Business Growth

Jun 21
We Think Starpharma Holdings (ASX:SPL) Can Afford To Drive Business Growth

Starpharma Holdings Limited (ASX:SPL): Is Breakeven Near?

May 16
Starpharma Holdings Limited (ASX:SPL): Is Breakeven Near?

Here's Why We're Not At All Concerned With Starpharma Holdings' (ASX:SPL) Cash Burn Situation

Mar 02
Here's Why We're Not At All Concerned With Starpharma Holdings' (ASX:SPL) Cash Burn Situation

Is There An Opportunity With Starpharma Holdings Limited's (ASX:SPL) 27% Undervaluation?

Feb 10
Is There An Opportunity With Starpharma Holdings Limited's (ASX:SPL) 27% Undervaluation?

Starpharma Holdings Limited (ASX:SPL) Is Expected To Breakeven In The Near Future

Jan 20
Starpharma Holdings Limited (ASX:SPL) Is Expected To Breakeven In The Near Future

Did You Miss Starpharma Holdings' (ASX:SPL) Impressive 105% Share Price Gain?

Dec 28
Did You Miss Starpharma Holdings' (ASX:SPL) Impressive 105% Share Price Gain?

How Does Starpharma Holdings' (ASX:SPL) CEO Salary Compare to Peers?

Dec 07
How Does Starpharma Holdings' (ASX:SPL) CEO Salary Compare to Peers?

CEO

Cheryl Maley (54 yo)

less than a year

Tenure

Mrs. Cheryl Maley, B.Sc, DipEd, MBA, GAICD, serves as Chief Executive Officer, Managing Director and Director of Starpharma Holdings Limited since January 8. 2024. She served as Non-Executive Director of C...


Board Members

NamePositionTenureCompensationOwnership
Cheryl Maley
CEO, MD & Directorless than a yearno datano data
Jacinth Fairley
Advisor to the Boardless than a yearAU$1.07m0.98%
A$ 506.9k
Robert Thomas
Non-Executive Chairman10.3yrsAU$134.00k0.23%
A$ 118.8k
David McIntyre
Non-Executive Director4yrsAU$81.00k0.0039%
A$ 2.0k
Jeff Davies
Non-Executive Director1.9yrsAU$75.00k0.012%
A$ 6.2k
Russell Basser
Non-Executive Director1.1yrsAU$27.01kno data
Lynda Cheng
Non-Executive Director2.6yrsAU$83.52k0.015%
A$ 7.5k

1.9yrs

Average Tenure

60yo

Average Age

Experienced Board: SPL's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.